Table 3.
Acute interventions to control supraventricular tachycardia in neonates.
| Treatment | Dosing | Comments |
|---|---|---|
| DC shock | ORT or AVNRT 0.25 J/kg A.flutter 0.5 J/kg A.fib 1–2 J/kg All of above double for each subsequent attempt |
|
| Adenosine | 0.1–0.3 mg/kg rapid IV bolus. Preferably administered via a venous access close to heart |
|
| Amiodarone | Loading 5 mg/kg over 20–60 min (infusion rate not exceeding 0.25 mg/kg/min); may repeat twice up to maximum total dose of 15 mg/kg during. Followed by initial: 10 mg/kg/day, increase incrementally as clinically needed range: 10–20 mg/kg/day. There is variability in the preferred administration rates and acute loading dosage of Amiodarone based on institutional preference. | Follow QTc interval on serial ECG. Baseline labs including complete blood count, thyroid function tests and liver enzymes is recommended when considering Amiodarone. |
| Esmolol | 0.5 mg/kg rapid IV bolus followed by 50–200 mcg/kg/min | Watch for exacerbation of bronchospasm in patients with asthma |
| Procainamide | 7–15 mg/kg IV over 15–30 min followed by 20–60 mcg/kg/min | Particularly useful in SVT involving AV bypass tracts and stable wide complex tachycardia. Dosing adjustment and serum drug concentrations recommended in hepatic/renal impairment. Drug levels also required in those receiving higher maintenance doses for >24 h. |
| Transesophageal Overdrive Pacing | A 4- to 7-French bi- to quadripolar intracardiac/5- to 10-French esophageal electrode catheter is introduced through the mouth/nose to the estimated depth (distance from the tip of the nose to about 2–5 cm above the xiphoid) in the esophagus. At that point, a transoesophageal stimulator is attached. After determination of the tachycardia cycle length, pacing is established at a cycle length at least 20–30 ms shorter than the spontaneous tachycardia cycle length. | A standard temporary external pacemaker might not provide sufficient impulse duration (10–15 ms) to capture the atrium with the lowest possible, yet effective amplitude tolerated by the patient. |
A.fib, atrial fibrillation; A.flutter, atrial flutter; ORT, orthodromic atrioventricular reentrant tachycardia; AV, atrioventricular; AVNRT, Atrioventricular nodal reentrant tachycardia; IART, intra-atrial reentrant tachycardia; IV, intravenous; WPW, Wolff-Parkinson-White syndrome.